Please login to the form below

Not currently logged in


This page shows the latest Theranos news and features for those working in and with pharma, biotech and healthcare.

Evolving at home

Evolving at home

The same is true for business behaviour. Theranos failed because the environment selected against the company’s shady behaviour.

Latest news

  • Genetic testing: nothing to write home about? Genetic testing: nothing to write home about?

    dark days of Theranos).

  • Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

    DIGITAL HEALTH. The inside story of Theranos’ health tech fraud. Published today is the book by Wall Street Journal reporter John Carreyou, Bad Blood: Secrets and Lies in a Silicon Valley ... Startup.  It tells the story of Theranos and its founder

  • Theranos and its CEO settle 'massive fraud' charges Theranos and its CEO settle 'massive fraud' charges

    During this time Silicon Valley-based Theranos, which wanted to revolutionise blood testing, raised more than $700 million from investors. ... Investors were also falsely told by Theranos that the US army used its blood analyser on the battlefield in

  • 2018 by Darwin 2018 by Darwin

    That’s what we learned from Theranos. Darwin, Dawkins and many of my other scientific heroes have been circumspect about the predictive power of evolutionary theory, and rightly so.

  • Acting at random Acting at random

    Looking from the outside, this seems to be Elizabeth Holme's problem at Theranos. ... Great technological and commercial capabilities but something went wrong in the part of Theranos's routineome that expresses the genes for regulatory capabilities.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...